{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:29:56Z","timestamp":1790260196941,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30971291"],"award-info":[{"award-number":["30971291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400176"],"award-info":[{"award-number":["81400176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572993"],"award-info":[{"award-number":["81572993"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Major Project","award":["2012zx09102301-015"],"award-info":[{"award-number":["2012zx09102301-015"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2014M560916"],"award-info":[{"award-number":["2014M560916"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.canlet.2016.07.019","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T19:00:58Z","timestamp":1469127658000},"page":"85-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically"],"prefix":"10.1016","volume":"381","author":[{"given":"Xiangfei","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.07.019_bib0010","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2016.07.019_bib0015","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2016.07.019_bib0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.surg.2011.02.005","article-title":"Operative injury accelerates tumor growth by inducing mobilization and recruitment of bone marrow-derived stem cells","volume":"149","author":"Takemoto","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.canlet.2016.07.019_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2016.07.019_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/jhep.2000.8525","article-title":"High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential","volume":"32","author":"Wang","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.07.019_bib0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.24075","article-title":"Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model","volume":"53","author":"Feng","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.07.019_bib0040","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00432-010-0848-1","article-title":"Long-term interferon-alpha treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma","volume":"136","author":"Zhuang","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.canlet.2016.07.019_bib0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","article-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","volume":"15","author":"Ebos","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2016.07.019_bib0050","article-title":"Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.07.019_bib0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cld.2015.01.009","article-title":"Systemic therapy of hepatocellular carcinoma: current and promising","volume":"19","author":"Kalyan","year":"2015","journal-title":"Clin. Liver Dis"},{"key":"10.1016\/j.canlet.2016.07.019_bib0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"Yamamoto","year":"2010","journal-title":"Mol. Ther"},{"key":"10.1016\/j.canlet.2016.07.019_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp100219n","article-title":"Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data","volume":"8","author":"Pesonen","year":"2011","journal-title":"Mol. Pharm"},{"key":"10.1016\/j.canlet.2016.07.019_bib0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.canlet.2016.07.019_bib0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00004836-200012000-00007","article-title":"Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels","volume":"31","author":"Tangkijvanich","year":"2000","journal-title":"J. Clin. Gastroenterol"},{"key":"10.1016\/j.canlet.2016.07.019_bib0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/cgt.2012.40","article-title":"Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression","volume":"19","author":"Zhang","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.canlet.2016.07.019_bib0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/gt.2011.16","article-title":"Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene","volume":"18","author":"Cao","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.canlet.2016.07.019_bib0090","first-page":"6428","article-title":"A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin","volume":"61","author":"Li","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.07.019_bib0095","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/JVI.80.4.2000-2012.2006","article-title":"Genetic identification of adenovirus type 5 genes that influence viral spread","volume":"80","author":"Subramanian","year":"2006","journal-title":"J. Virol"},{"key":"10.1016\/j.canlet.2016.07.019_bib0100","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1038\/onc.2008.274","article-title":"MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death","volume":"27","author":"Schickel","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.07.019_bib0105","doi-asserted-by":"crossref","first-page":"e1000440","DOI":"10.1371\/journal.ppat.1000440","article-title":"Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells","volume":"5","author":"Cawood","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.canlet.2016.07.019_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054506","article-title":"MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver","volume":"8","author":"Yl\u00f6sm\u00e4ki","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.07.019_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008916","article-title":"Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability","volume":"5","author":"Leja","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.07.019_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016152","article-title":"MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity","volume":"6","author":"Cawood","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.07.019_bib0125","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1038\/sj.onc.1209044","article-title":"Oncolytic adenoviruses-selective retargeting to tumor cells","volume":"24","author":"Mathis","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.07.019_bib0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.mt.6300128","article-title":"Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy","volume":"15","author":"Hamada","year":"2007","journal-title":"Mol. Ther"},{"key":"10.1016\/j.canlet.2016.07.019_bib0135","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jnci\/djt141","article-title":"A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy","volume":"105","author":"Ahmed","year":"2013","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.canlet.2016.07.019_bib0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1476-4598-10-134","article-title":"Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors","volume":"10","author":"Xia","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2016.07.019_bib0145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1634\/stemcells.2007-0758","article-title":"Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma","volume":"26","author":"Sonabend","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2016.07.019_bib0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-006-9449-8","article-title":"Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma","volume":"105","author":"Stoff-Khalili","year":"2007","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.canlet.2016.07.019_bib0155","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.3390\/ijms140611692","article-title":"Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications","volume":"14","author":"Kim","year":"2013","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.canlet.2016.07.019_bib0160","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.biomaterials.2013.12.037","article-title":"Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter","volume":"35","author":"Yan","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2016.07.019_bib0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.exphem.2012.11.001","article-title":"Gene therapy in B-NHL cell line using adenovirus-mediated transfer of secretable trimeric TRAIL gene expression driven by CD20 promoter","volume":"41","author":"Yuan","year":"2013","journal-title":"Exp. Hematol"},{"key":"10.1016\/j.canlet.2016.07.019_bib0170","first-page":"1987","article-title":"Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiation into nerve-like cells","volume":"118","author":"Ma","year":"2005","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.canlet.2016.07.019_bib0175","doi-asserted-by":"crossref","first-page":"1977e87","DOI":"10.1007\/s00262-012-1256-y","article-title":"Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated salmonella, on orthotopically implanted hepatocarcinoma","volume":"61","author":"Jia","year":"2012","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2016.07.019_bib0180","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1158\/1535-7163.MCT-12-0157","article-title":"MicroRNA regulation of oncolytic adenovirus 6 for selective treatment of castration-resistant prostate cancer","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2016.07.019_bib0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jhep.2008.01.019","article-title":"MiR-122, a paradigm for the role of microRNAs in the liver","volume":"48","author":"Girard","year":"2008","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2016.07.019_bib0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1478-811X-10-26","article-title":"Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment","volume":"10","author":"Hass","year":"2012","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.canlet.2016.07.019_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12307-014-0151-9","article-title":"Tumor-driven molecular changes in human mesenchymal stromal cells","volume":"8","author":"Kucerova","year":"2015","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.canlet.2016.07.019_bib0200","article-title":"A model of cancer stem cells derived from mouse induced pluripotent stem cells","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516304268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516304268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:55:33Z","timestamp":1536573333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516304268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0304383516304268"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.07.019","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}